Medtronic receives FDA approval for thoracic stent graft

TriMed Staff | | Health Imaging | Diagnostic Imaging
The FDA has granted approval for Medtronic’s Talent thoracic stent graft, a medical device that will allow more patients to benefit from a minimally invasive treatment for certain types of aneurysms of the descending thoracic aorta.

The Talent thoracic stent graft system makes thoracic endovascular aortic repair (EVAR) accessible to an additional 25 percent of patients because it is available in a range of diameters—from 22 mm to 46 mm, according to the Minneapolis-based Medtronic.

In April, Medtronic received FDA approval for its Talent abdominal stent graft for EVAR of abdominal aortic aneurysms.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.